An Act authorizing a pilot for the use of psychedelics in licensed treatment facilities
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Overview
This bill proposes a pilot program in Massachusetts to explore the potential use of psychedelics, such as psilocybin, in licensed treatment facilities for mental health and substance use disorders. The program would involve carefully controlled settings and qualified professionals. It aims to investigate whether these substances can be a helpful therapeutic tool alongside traditional treatments.
Key provisions
- Establishment of a pilot program for psychedelic-assisted therapy.
- Designation of licensed treatment facilities to participate in the pilot.
- Requirements for qualified professionals administering the treatments.
- Protocols for patient screening and monitoring.
- Data collection and reporting on the program's effectiveness and safety.
- Restrictions on the types of psychedelics that can be used.
- Guidelines for patient consent and informed decision-making.
Who is affected
- Individuals with mental health disorders
- Individuals with substance use disorders
- Licensed treatment facilities
- Mental Health professionals
- The healthcare industry
Notable changes
- This bill would legalize a pilot program for psychedelic-assisted therapy, which is currently prohibited in Massachusetts.
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
3 on record
Primary sponsor
James J. O'Day
Cosponsors
James J. O'Day
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours